Technology Transfer is the process of moving inventions, discoveries, research tools, and other intellectual property to the world outside. At Providence, our focus is on facilitating technology transfer processes that are most beneficial to patients and society.

In its broadest definition, intellectual property is any work, invention, or discovery you create. This includes intellectual property that can be formally protected with patents, copyright, or trademarks as well as tangible items that can be protected by restricting access (for example, data, research reagents, software, and assessments.)

Our office leads the efforts to protect and commercialize Providence intellectual property and advise the Providence community on options for managing their intellectual property. We offer a breadth of IP related services that include:

-Presenting options for protecting IP rights

-Evaluating commercial potential of inventions

-Patenting inventions

-Identifying opportunities for collaboration with industry

-Licensing intellectual property

-Negotiating and administering partnership agreements such as material transfer, confidentiality, collaboration, and sponsored research agreements

-Creating new businesses based on Providence technologies

Follow

Submissions from 2018

Link

Galectin - Method for Enhancing Specific Immunotherapies in Cancer Treatment, Peter G. Traber, William L. Redmond, Eliezer Zomer, Anatole Klyosov, and Stephanie N. Linch

Submissions from 2016

Link

Image processing method and system for analyzing a multi-channel image obtained from a biological tissue sample being stained by multiple stains, Michael Barnes, Carlo Bifulco, Ting Chen, and Alisa Tubbs

Submissions from 2015

Link

Chitosan Foam Medical Devices and Methods, Jian Xin Guo and Kenton W. Gregory

Link

Allogeneic autophagosome-enriched composition for the treatment of disease, Traci Hilton, Sandra Aung, Rieneke van de Ven, Christopher Paustian, Tarsem Moudgil, Christopher Dubay, Christopher Twitty, Hong-Ming Hu, and Bernard A Fox

Link

Methods and compositions for inducing an immune response to EGFRvIII, Peter M. Lauer and Ketih Bahjat

Link

Chitosan wound dressing, Simon J. McCarthy

Link

Immunogenic compositions comprising silicified virus and methods of use, Kenneth M. Stedman, James R. Laidler, and Keith Bahjat

Submissions from 2014

Link

Cancer treatment and monitoring methods using OX40 agonists, Brendan Curti, Magdalena Kovacsovics-Bankowski, Ed Walker, Josh Walker, and Andy Weinberg

Link

Chitosan wound dressing, Simon J. McCarthy

Link

Ubiquitinylated proteins, Christopher Twitty, Erik LeShane, Bernard A Fox, Hong-Ming Hu, and Guangjie Yu

Submissions from 2013

Link

Allogeneic autophagosome-enriched composition for the treatment of disease, Traci Hilton, Sandra Aung, Rieneke van de Ven, Christopher Paustian, Tarsem Moudgil, Christopher Dubay, Christopher Twitty, Hong-Ming Hu, and Bernard A. Fox

Link

Methods and compositions for inducing an immune response to EGFRvIII, Peter M. Lauer and Keith Bahjat

Link

Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer types, Partha S. Ray, Sanjay Bagaria, Xiaojiang Cui, and Jinhua Wang

Link

Method for enhancing specific immunotherapies in cancer treatment, Peter G. Traber, William L. Redmond, Eliezer Zomer, Anatole Klyosov, and Stefanie N. Linch

Link

Molecular malignancy in melanocytic lesions, Hui Wang, Christopher Roberts, Krishna Maddula, Zhenquiang Lu, Tom Vasicek, BJ Kerns, Bruce E. Seligmann, and Dave S B Hoon

Submissions from 2012

Link

Utility of B-RAF DNA mutation in diagnosis and treatment of cancer, Dave S B Hoon

Link

Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer, Dave S B Hoon and Laurent Lessard

Submissions from 2011

Link

Treatment of cancer and compositions, Richard Essner

Link

Method and apparatus for in vivo collection of circulating biological components, Dave S B Hoon, Bret Taback, and Samuel Shaolian

Link

Method and apparatus for in vivo surveillance of circulating biological components, Dave S B Hoon, Bret Tabeck, and Samuel Shaolian

Submissions from 2010

Link

Chitosan wound dressing, Staci Ann McAdams, William David Block, Simon John McCarthy, Kenton W. Gregory, and Hal Oien

Link

Chitosan wound dressing, Simon J. McCarthy, Kenton W. Gregroy, William P. Wiesmann, and Todd D. Campbell

Submissions from 2009

Link

Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer, Dave S B Hoon and Michiel de Maat

Link

Use of ID4 for diagnosis and treatment of cancer, Dave S B Hoon and Naoyuki Umetani

Link

Wound dressing devices and methods, Lisa Lucchesi and Hue Xia

Link

Trimeric OX40-immunoglobulin fusion protein and methods of use, Andrew D Weinberg, Nicholas P. Morris, and Carmen Romerdaue

Submissions from 2008

Link

Utility of B-RAF DNA mutation in diagnosis and treatment of cancer, Dave S B Hoon

Link

Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer, Dave S B Hoon and Michiel de Maat

Link

Utility of RET mutant in diagnosis and treatment of melanoma, Dave S B Hoon, Norihiko Narita, and Atsushi Tanemura

Link

Method and apparatus for in vivo collection of circulating biological components, Dave S B Hoon, Bret Taback, and Samual Shaolian

Link

Method and apparatus for in vivo surveillance of circulating biological components, Dave S B Hoon, Bret Taback, and Samuel Shaolian

Link

Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response, Hong-Ming Hu

Submissions from 2007

Link

Systems and Methods for Introducing and Applying a Bandage Structure Within a Body Lumen or Hollow Body Organ, Kenton W. Gregory and Amanda Dayton

Link

Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding, Kenton W. Gregory and Simon McCarthy

Link

Methylation of estrogen receptor alpha and uses thereof, Dave S B Hoon

Link

Chitosan wound dressing, Simon McCarthy, Barbara McGrath, and Ervelyn Winata

Submissions from 2006

Link

Use of ID4 for diagnosis and treatment of cancer, Dave S B Hoon and Naoyuki Umetani

Link

Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan, Simon J. McCarthy

Submissions from 2005

Link

Systems and methods for hemorrhage control and or tissue repair, Kenton W. Gregory; Paul F. Bente, IV; Heather Margaret Bryan; Jeffrey Yihyuan Lin; Aileen Nuguid; and Daniel Allen Pederson

Link

Detection of cancer cells in body fluids, Dave S B Hoon

Link

Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan, Staci Ann McAdams, William David Block, Simon John McCarthy, and Kenton W. Gregory

Link

Biocompatible denatured albumin biomaterial, Yasmin Wadia and Scott Alan Prahl

Submissions from 2004

Link

Wound dressing and method for controlling severe, life-threatening bleeding, Kenton W. Gregory and Simon McCarthy

Link

DNA markers for management of cancer, Dave S B Hoon and Bret Taback

Link

Method and apparatus for in vivo collection of circulating biological components, Dave S B Hoon, Bret Taback, and Samuel Shaolian

Submissions from 2003

Link

Molecular lymphatic mapping of sentinel lymph nodes, Dave S B Hoon and Bret Taback

Link

Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR, Dave S B Hoon and Hiroya Takeuchi

Link

Wound dressing and method for controlling severe, life-threatening bleeding, Simon J. McCarthy, Kenton W. Gregory, William P. Wiesmann, and Todd D. Campbell

Submissions from 2000

Link

Methods for lymph node identification, Donald L. Morton

Link

Biocompatible albumin lamina and method, Yasmin Wadia and Scott Alan Prahl